Konrad Steinestel Selected Research

Konrad Steinestel Research Topics

Disease

23	Neoplasms (Cancer) 01/2021 - 01/2014
7	Prostatic Neoplasms (Prostate Cancer) 06/2019 - 10/2014
6	Carcinoma (Carcinomatosis) 02/2022 - 01/2013
6	Colorectal Neoplasms (Colorectal Cancer) 11/2020 - 01/2012
5	Adenocarcinoma 01/2020 - 01/2017
4	Neoplasm Metastasis (Metastasis) 01/2019 - 01/2012
3	Inflammation (Inflammations) 01/2022 - 01/2012
3	Hypoxia (Hypoxemia) 02/2021 - 01/2016
3	Melanoma (Melanoma, Malignant) 11/2020 - 07/2015
2	Carcinogenesis 06/2022 - 01/2012
2	COVID-19 01/2022 - 01/2020
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2022 - 01/2017
2	Disease Progression 01/2021 - 01/2020
2	Myxoid Liposarcoma 01/2019 - 10/2017
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2017 - 04/2015
2	Infections 05/2015 - 01/2013
1	Head and Neck Neoplasms (Head and Neck Cancer) 02/2022
1	Pulmonary Fibrosis (Fibrosing Alveolitis) 01/2022
1	Fibrosis (Cirrhosis) 01/2022
1	Respiratory Insufficiency (Respiratory Failure) 01/2022
1	Radiation Injuries (Radiation Sickness) 01/2022
1	Enteritis 01/2022
1	Urinary Bladder Neoplasms (Bladder Cancer) 01/2022
1	B-Cell Lymphoma (Lymphoma, B Cell) 02/2021
1	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 02/2021
1	Glioblastoma (Glioblastoma Multiforme) 02/2021
1	Renal Cell Carcinoma (Grawitz Tumor) 01/2021
1	Squamous Cell Carcinoma of Head and Neck 11/2020
1	Multiple Myeloma 04/2020
1	Metaplasia 01/2020
1	Pancreatitis 01/2020
1	Ewing Sarcoma (Sarcoma, Ewing) 01/2020
1	Epithelioid Hemangioendothelioma 10/2019
1	Osteolysis 10/2019
1	Circulating Neoplastic Cells 06/2019
1	Autistic Disorder (Autism) 04/2019
1	Synovial Sarcoma (Synovioma) 01/2019
1	Colitis 11/2018
1	Wounds and Injuries (Trauma) 11/2018
1	Thyroid Neoplasms (Thyroid Cancer) 02/2018
1	Papillary Thyroid Cancer 01/2018
1	Fibrosarcoma 10/2017
1	Sarcoma (Soft Tissue Sarcoma) 01/2017
1	Breast Neoplasms (Breast Cancer) 05/2016

Drug/Important Bio-Agent (IBA)

13	Proteins (Proteins, Gene)FDA Link 01/2022 - 01/2012
6	Biological ProductsIBA 02/2022 - 01/2017
4	Messenger RNA (mRNA)IBA 01/2022 - 01/2014
4	AndrogensIBA 06/2019 - 10/2014
3	Phosphotransferases (Kinase)IBA 06/2022 - 01/2013
3	Biomarkers (Surrogate Marker)IBA 01/2021 - 01/2013
3	Heterogeneous-Nuclear Ribonucleoprotein KIBA 11/2020 - 07/2015
3	AntigensIBA 02/2018 - 01/2017
2	Transcription Factors (Transcription Factor)IBA 06/2022 - 01/2019
2	Hormones (Hormone)IBA 10/2019 - 10/2014
2	Androgen Receptors (Androgen Receptor)IBA 06/2019 - 01/2017
2	MicroRNAs (MicroRNA)IBA 09/2018 - 01/2014
2	Cadherins (E-Cadherin)IBA 09/2018 - 01/2013
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 09/2017 - 01/2016
2	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2017 - 07/2015
2	edelfosineIBA 05/2016 - 01/2016
2	Calcium-Activated Potassium Channels (Calcium-Activated Potassium Channel)IBA 05/2016 - 01/2016
2	Cyclin-Dependent Kinase Inhibitor p16IBA 04/2015 - 01/2013
1	Platelet-Derived Growth Factor beta Receptor (Receptor, Platelet Derived Growth Factor beta)IBA 01/2022
1	GlucosidesIBA 01/2022
1	AntioxidantsIBA 01/2022
1	Ascorbic Acid (Vitamin C)FDA LinkGeneric 01/2022
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 02/2021
1	Bevacizumab (Avastin)FDA Link 02/2021
1	Chloroquine (Aralen)FDA LinkGeneric 02/2021
1	Immune Checkpoint InhibitorsIBA 01/2021
1	Heterogeneous-Nuclear Ribonucleoproteins (Informatin)IBA 11/2020
1	LigandsIBA 04/2020
1	GTP Phosphohydrolases (GTPases)IBA 01/2020
1	ras ProteinsIBA 01/2020
1	AutoantibodiesIBA 01/2020
1	Focal Adhesion Protein-Tyrosine KinasesIBA 01/2020
1	Verteporfin (Visudyne)FDA Link 01/2019
1	CortactinIBA 01/2019
1	CytokinesIBA 11/2018
1	Fibronectins (Fibronectin)IBA 09/2018
1	VimentinIBA 09/2018
1	Anaplastic Lymphoma KinaseIBA 01/2018
1	Protein Kinases (Protein Kinase)IBA 09/2017
1	Oxygen (Dioxygen)IBA 09/2017
1	Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA 09/2017
1	enzalutamideIBA 01/2017
1	binimetinibIBA 01/2017
1	abirateroneIBA 01/2017
1	4-O-carboxymethylascochlorinIBA 01/2017

Therapy/Procedure

11	Therapeutics 01/2021 - 01/2014
3	Radiotherapy 01/2022 - 07/2015
2	Drug Therapy (Chemotherapy) 01/2022 - 01/2017
2	Immunotherapy 01/2022 - 01/2021
2	Chemoradiotherapy 02/2021 - 12/2018
2	Castration 01/2017 - 05/2015
1	Molecular Targeted Therapy 06/2022
1	Adjuvant Chemoradiotherapy 02/2021
1	Heterologous Transplantation (Xenotransplantation) 11/2020
1	Stem Cell Transplantation 04/2020
1	Neoadjuvant Therapy 12/2018